Tumour necrosis factor alpha-induced neuronal loss is mediated by microglial phagocytosis

Urte Neniskyte1, Anna Vilalta2, Guy C Brown2

  • 1Department of Biochemistry, University of Cambridge, UK; Mouse Biology Unit, European Molecular Biology Laboratory, Italy.

FEBS Letters
|June 10, 2014
PubMed

Insights

Tumour necrosis factor-α (TNF-α) drives neuronal loss by activating microglia to phagocytose neurons. Inhibiting microglial phagocytosis prevents this TNF-α-induced neurodegeneration, revealing a mechanism called phagoptosis.

Area of Science:

  • Neuroscience
  • Immunology
  • Cell Biology

Background:

  • Tumour necrosis factor-α (TNF-α) is a pro-inflammatory cytokine implicated in various brain pathologies.
  • TNF-α is associated with neuronal loss in neurological conditions.

Purpose of the Study:

  • To investigate the role of TNF-α in neuronal loss.
  • To elucidate the mechanism by which TNF-α induces neurodegeneration, focusing on microglial involvement.

Main Methods:

  • Utilized neuronal-glial co-cultures treated with TNF-α.
  • Assessed microglial proliferation and phagocytosis.
  • Investigated the effect of blocking microglial phagocytic receptors (vitronectin and P2Y6) and MFG-E8.

Main Results:

  • TNF-α increased microglial proliferation and phagocytosis in co-cultures.
  • Neuronal loss was observed following TNF-α treatment.
  • Eliminating microglia or inhibiting microglial phagocytosis prevented TNF-α-induced neuronal death.
  • Blocking specific phagocytic pathways (vitronectin, P2Y6, MFG-E8) abrogated TNF-α-mediated neurotoxicity.

Conclusions:

  • TNF-α induces neuronal loss primarily through microglial activation and subsequent phagocytosis of neurons.
  • This process, termed phagoptosis, represents a key mechanism of neurodegeneration in the context of TNF-α signaling.